78,270 Shares in Henry Schein, Inc. $HSIC Bought by Cubist Systematic Strategies LLC

Key Points

• Cubist Systematic Strategies LLC purchased 78,270 shares of Henry Schein, Inc., valued at approximately $5,361,000, increasing its ownership to about 0.06% as of the end of the last quarter.
• Several hedge funds have recently increased their stakes in Henry Schein, indicating significant institutional interest in the stock, with 96.62% of ownership held by hedge funds and other institutional investors.
• Analysts have reduced their price targets for Henry Schein, with the consensus target price now at $76.67, reflecting a cautious outlook for the company despite a recent earnings report that showed a 3.3% year-over-year revenue growth.

Cubist Systematic Strategies LLC purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 78,270 shares of the company's stock, valued at approximately $5,361,000. Cubist Systematic Strategies LLC owned about 0.06% of Henry Schein as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Investment Management Corp VA ADV purchased a new stake in Henry Schein in the 4th quarter valued at approximately $32,000. Rakuten Securities Inc. bought a new position in shares of Henry Schein during the 1st quarter worth about $34,000. Whittier Trust Co. lifted its position in shares of Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares in the last quarter. Quarry LP bought a new stake in shares of Henry Schein during the first quarter worth $71,000. Finally, UMB Bank n.a. grew its position in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after acquiring an additional 201 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded down $1.76 during midday trading on Monday, hitting $67.67. The company's stock had a trading volume of 932,741 shares, compared to its average volume of 1,747,986. The stock has a market capitalization of $8.21 billion, a price-to-earnings ratio of 21.81, a PEG ratio of 2.29 and a beta of 0.86. The stock's 50 day simple moving average is $69.92 and its 200 day simple moving average is $69.68. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein's quarterly revenue was up 3.3% on a year-over-year basis. During the same period last year, the firm earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HSIC shares. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Sunday. Barrington Research lowered their price target on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target for the company in a research note on Tuesday, August 26th. Stifel Nicolaus reissued a "hold" rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Finally, Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, Henry Schein currently has an average rating of "Hold" and a consensus price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.